With 2 ETFs traded on the U.S. markets, Loncar ETFs have total assets under management of $63.89M. The average expense ratio is 0.79%. Loncar ETFs can be found in the following asset classes:
The largest Loncar ETF is the Loncar Cancer Immunotherapy ETF CNCR with $45.65M in assets. In the last trailing year, the best-performing Loncar ETF was CHNA at 42.33%. The most recent ETF launched in the Loncar space was the Loncar China BioPharma ETF CHNA on 08/14/18.